Borman Mark P 4
4 · U.S. Stem Cell, Inc. · Filed Aug 25, 2017
Insider Transaction Report
Form 4
Borman Mark P
Director
Transactions
- Award
Stock Option (right to buy)
2017-08-07+1,500,000→ 3,002,810 totalExercise: $0.03From: 2017-08-07Exp: 2017-08-07→ Common Stock (1,500,000 underlying)
Holdings
- 24(indirect: By Trust)
Common Stock